The U.S. Food and Drug Administration has approved an Abbreviated New Drug Application (ANDA) numbered ANDA076367 for a topical ointment containing the corticosteroid amcinonide.
The product, marketed under the brand name AMCINONIDE, is a prescription ointment with a 0.1% strength, administered topically. It is manufactured by Sun Pharmaceutical Industries, Inc. and sponsored by TARO PHARM INDS. The FDA’s original submission (ORIG) received an approved status (AP) on March 19, 2003. Current marketing status is listed as Discontinued. Associated National Drug Code (NDC) identifiers include 51672-4054-4, 51672-4054-1, 51672-4054-2, 51672-4054-3, 51672-4060-1, 51672-4060-2, and 51672-4060-3.
規制動向2026年9月17日•3分で読めます
FDA Approves ANDA076367 for Amcinonide Topical Ointment
FDA approved ANDA076367 for a 0.1% amcinonide prescription ointment; the product is currently listed as discontinued.
Pharmacountryチームがまとめました · 出典： FDA.gov
トピック：
評価
(0)
(0)
(0)
(0)
(0)
評価を残す